Deutsche Bank’s shares fell 6.21% on Friday, after the bank unveiled weak Q4 figures and a third consecutive year of losses. Germany’s biggest bank reported net losses of 497 million euros in 2017, following losses of 1.35 billion in 2016 and 6.77 billion in 2015.
ArcelorMittal, the leading global integrated steel and mining firm, said it posted net profit of 4.568 billion dollars in 2017 (3.670 billion euros), 157% up from a year earlier. It will also pay a dividend again for the first time since 2015.
If there is something that the months of January have in common every year are the numerous sectorial reviews which every analyst consensus makes. Tradition focuses on 12 companies in the Stoxx600 with a recent buy recommendation.
Abengoa is considering selling the remaining 16.5% stake it holds in Atlantica Yield and some investment funds could be interested, press reports say.
Abengoa has signed a contract with Algonquin Power & Utilities Corp. (APUC), which provides public services in the renewable and regulated energy sector, for the sale of a 25% stake in Atlantica Yield for $607 million.
While the telecoms sector (mainly represented by Telefónica) is very attractive for investors, “looming pressure on returns” is clouding investor interest in the utilities.
Sonia Ruiz de Garibay (GVCGaesco) | Although a simultaneous investment recommendation for oil and airline stocks might seem a contradiction in terms, the fact they are both heavily influenced by oil prices gives them a very important element in common. Oil is an earning driver for the oil industry, while for the airlines sector it is an important costs’ element, accounting for over 20% of the total. Repsol and IAG are currently good bets.
Carax Alphavalue |The European pharmaceutical sector hit record highs almost two years ago, since when it has had an overall disappointing performance. So far this year, there has been no sign of its defensive qualities, although it continues to pay attractive dividends.
Spanish pharmaceutical and healthcare firm Grifols has obtained approval from the US Food and Drug Administration (FDA) to market the physiological saline solution which the company manufactures at its plant in Las Torres de Cotillas (Murcia). This is very positive for the group’s hospital division and, in particular, for its presence in the US.
ACS’ subsidiary Cobra has won a contract worth 126 million euros to build various electricity transmission lines in Brazil, boosting its portfolio of these projects in that country to 3 billion euros.